We addressed these limitations by studying a group of otherwise healthy adults with overweight/obesity and without type 2 diabetes or other end‐organ dysfunction, and by measuring fasting serum myostatin levels using a validated LC–MS/MS assay with excellent sensitivity and specificity. Here, MSTN is linked to obesity disorder.